文献速递脑血管病外科

治疗时期对脑动静脉畸形立体定向放射外科治疗后结局的影响:一项国际多中心研究

Effect of treatment period on outcomes after stereotactic radiosurgery for brain arteriovenous malformations: an international multicenter study.
PubMed 文献 · J Neurosurg · 2018-02-02

这项国际多中心回顾性队列研究比较了早期(1988-2000年)与现代(2001-2014年)立体定向放射外科(SRS)治疗脑动静脉畸形(AVM)的结局,共纳入2248例患者。早期SRS组AVM体积更小、边缘剂量更高,闭塞率显著更高(65% vs 51%,p<0.001),但不良结局如出血和放射性改变无显著差异。多因素分析中早期治疗时期是闭塞的独立预测因素,但对良好结局无统计学显著性。

要点

  • 早期SRS组AVM闭塞率显著高于现代组(65% vs 51%,p<0.001)。
  • 早期SRS组良好结局比例显著更高(61% vs 45%,p<0.001),但多因素分析无统计学显著性(p=0.470)。
  • 两组治疗后出血及放射性改变发生率无显著差异。

核心结论

  • 尽管SRS技术、AVM选择和综合治疗有所进步,研究未观察到SRS良好结局或闭塞率随时间的实质性改善。
  • 基线AVM特征和SRS治疗参数的差异可能部分解释现代SRS时代闭塞率显著较低。
  • 作者认为需要改进患者选择和剂量规划以优化SRS在现代AVM管理中的效用。

研究设计与样本

  • 多中心回顾性队列研究,纳入1988年至2014年间在8个中心接受单次SRS且随访≥6个月的AVM患者。
  • SRS时代分为早期(1988-2000年)和现代(2001-2014年),比较两组基线特征和结局。
  • 共纳入2248例患者,早期组1584例,现代组664例。

主要发现

  • 早期SRS组AVM最大直径和体积显著更小(p<0.001),放射外科边缘剂量显著更高(p<0.001)。
  • 早期SRS组闭塞率显著更高(65% vs 51%,p<0.001),早期治疗时期是多因素分析中闭塞的独立预测因素(p<0.001)。
  • 两组SRS后出血率及影像学、症状性、永久性放射性改变发生率无显著差异。
  • 早期SRS组良好结局比例显著更高(61% vs 45%,p<0.001),但多因素分析中早期治疗时期对良好结局无统计学显著性(p=0.470)。

关键数值与推荐

  • 良好结局定义为AVM闭塞、无SRS后出血且无永久性症状性放射性改变。
  • 早期SRS组闭塞率65% vs 现代SRS组51%(p<0.001)。
  • 早期SRS组良好结局61% vs 现代SRS组45%(p<0.001)。
  • 多因素分析中早期治疗时期对闭塞的预测p<0.001,对良好结局的预测p=0.470。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The role of and technique for stereotactic radiosurgery (SRS) in the management of arteriovenous malformations (AVMs) have evolved over the past four decades. The aim of this multicenter, retrospective cohort study was to compare the SRS outcomes of AVMs treated during different time periods. METHODS: The authors selected patients with AVMs who underwent single-session SRS at 8 different centers from 1988 to 2014 with follow-up ≥ 6 months. The SRS eras were categorized as early (1988-2000) or modern (2001-2014). Statistical analyses were performed to compare the baseline characteristics and outcomes of the early versus modern SRS eras. Favorable outcome was defined as AVM obliteration, no post-SRS hemorrhage, and no permanently symptomatic radiation-induced changes (RICs). RESULTS: The study cohort comprised 2248 patients with AVMs, including 1584 in the early and 664 in the modern SRS eras. AVMs in the early SRS era were significantly smaller (p < 0.001 for maximum diameter and volume), and they were treated with a significantly higher radiosurgical margin dose (p < 0.001). The obliteration rate was significantly higher in the early SRS era (65% vs 51%, p < 0.001), and earlier SRS treatment period was an independent predictor of obliteration in the multivariate analysis (p < 0.001). The rates of post-SRS hemorrhage and radiological, symptomatic, and permanent RICs were not significantly different between the two groups. Favorable outcome was achieved in a significantly higher proportion of patients in the early SRS era (61% vs 45%, p < 0.001), but the earlier SRS era was not statistically significant in the multivariate analysis (p = 0.470) with favorable outcome. CONCLUSIONS: Despite considerable advances in SRS technology, refinement of AVM selection, and contemporary multimodality AVM treatment, the study failed to observe substantial improvements in SRS favorable outcomes or obliteration for patients with AVMs over time. Differences in baseline AVM characteristics and SRS treatment parameters may partially account for the significantly lower obliteration rates in the modern SRS era. However, improvements in patient selection and dose planning are necessary to optimize the utility of SRS in the contemporary management of AVMs.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Patibandla MR, Ding D, Kano H, et al. Effect of treatment period on outcomes after stereotactic radiosurgery for brain arteriovenous malformations: an international multicenter study. J Neurosurg. 2018. PMID: 29393755. doi:10.3171/2017.8.JNS171336

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。